• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2004

View Archived Issues

Apomorphine reported safe and effective in advanced Parkinson's disease

Read More

Good safety profile of testosterone and sildenafil in hypogonadal men with ED

Read More

Novel PAF antagonist protects eyes against alkali and light-induced damage

Read More

Potent neuron survival-promoting agent for treatment of acute and chronic brain injury

Read More

Extension of Lilly/Isis antisense drug discovery collaboration in cancer

Read More

The Medicines Company continues to progress in late-stage development programs

Read More

Roche continues progress during first quarter

Read More

Bisphosphonate YM-529 effective in arthritic inflammation

Read More

Antisense therapy for growth hormone disorders

Read More

Dendrimer therapy effective against excessive post-eye surgery scarring

Read More

Inhibition of cytokine release with JTE-607 attenuates acid-induced lung injury

Read More

Three series of inhibitors of CDK2 and other kinases presented by Schering-Plough

Read More

Ilex presents HMG-CoA reductase lowering agents and their use in bone disorders

Read More

Schering AG claims CDK inhibitors with utility in cancer and other disorders

Read More

New PDE7 inhibitors in early development at Pfizer

Read More

New 5-HT4 receptor agonists prepared and tested by Pfizer scientists

Read More

Roche describes new MAO-B inhibitors for AD and senile dementia therapy

Read More

Sumitomo discontinues SMP-140

Read More

Mayne launches Paxene in E.U.

Read More

Progression of Axonyx phase IIb trial of phenserine

Read More

Endo plans new trial in support of oxymorphone extended-release NDA

Read More

Symbollon acquires safety data from Mimetix

Read More

Biolex acquires Epicyte Pharmaceutical

Read More

Series E financing to advance MorphoChem compounds into clinic

Read More

NIH licenses rotavirus vaccine to BIOVIRx

Read More

Sanofi-Synthelabo files registration statement with SEC regarding Aventis

Read More

Malarone shows no impact on alertness and performance tasks

Read More

Eisai and Abbott amend Japanese agreement for KES-524

Read More

Duloxetine adds to efficacy of pelvic muscle training in urinary incontinence

Read More

Intranasal PT-141 demonstrates efficacy in erectile dysfunction

Read More

Rigiscan study shows TA-1790 acts more rapidly than sildenafil

Read More

Pharmacokinetics of DA-8159 favorable in healthy subjects

Read More

Baclofen reported to reduce drug use in cocaine-dependent subjects

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 12, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe